Aviado · Research
Longevity Daily
Thursday, May 7, 2026
Listen
Today's Brief
Precision over volume is today's throughline — who you are determines what actually works. The Washington Post names the one brain supplement with clinical evidence to slow cognitive aging by two years, making it today's must-read; a companion Mayo Clinic study published in Alzheimer's & Dementia adds urgency by pinpointing age 70 as the inflection point when key biomarkers accelerate. Aviado's L-citrulline deep-dive delivers the same targeted logic for blood pressure, and creatine earns fresh evidence as a power-training synergist for older adults. Alector's halted Phase 2 Alzheimer's trial is a sobering reminder of how hard disease modification remains.
10 stories4 peer-reviewed1 trials1 Aviado original
Cognitive Health & Neuroprotection
Only One Brain Supplement Has Clinical Evidence to Slow Cognitive Aging — Here's Which One
The brain supplement market is booming, but a Washington Post review with a leading longevity expert cuts through the noise with a blunt finding: only one compound has been shown in clinical trials to slow cognitive aging, by approximately two years. The piece surveys popular options — from phosphatidylserine to lion's mane to omega-3s — and applies a rigorous evidentiary filter that most health journalism skips entirely. For the typical supplement stack-builder, the conclusion is clarifying if humbling: most of what's on the shelf lacks meaningful human trial data. This is required reading before your next supplement order.
Read more →Mayo Clinic Identifies Age 70 as the Tipping Point for Alzheimer's Biomarker Acceleration
A large Mayo Clinic study published in Alzheimer's & Dementia found that several key Alzheimer's disease biomarkers — along with measures of global cognition — undergo significantly accelerated age-related changes starting around age 70. If you're approaching your seventh decade, this is a signal to get serious about prevention now, not later. The findings underscore the urgency of the pre-70 window for lifestyle, dietary, and screening interventions.
Read more →Eating Eggs Five Times a Week Linked to 27% Lower Alzheimer's Risk
A new observational study found that eating eggs five times a week was associated with a 27% reduced risk of Alzheimer's disease, while even moderate consumption (one to three times per month) correlated with a 17% risk reduction — a dose-response pattern that adds credibility. The likely mechanism is choline, a nutrient critical to brain cell membrane integrity that most Americans chronically under-consume. Caveat: this is observational data, not a controlled trial, so it can't establish causation — but the consistency across intake levels makes it worth taking seriously.
Read more →Supplements & Compounds
Creatine Amplifies Power Training Benefits in Older Adults, New Study Finds
A new study covered by Lifespan.io found that creatine supplementation combined with power training produced greater improvements in physical performance for older adults than exercise alone — extending the case for creatine well beyond younger athletes. Creatine's benefits in aging populations go beyond muscle: the compound also supports brain energy metabolism, making it one of the most evidence-backed options in the 50+ supplement toolkit. If you're already doing resistance training but haven't added creatine, this study gives you a compelling reason to reconsider.
Read more →L-Citrulline Drops Blood Pressure Up to 9 mmHg — But Only for the Right People
Aviado's latest analysis cuts through the hype: L-citrulline is real medicine for specific people — postmenopausal women with hypertension, older adults with arterial stiffness, and cold-sensitive individuals — delivering systolic reductions of 4–9 mmHg within 8–12 weeks. If you don't fall into those categories, your vasculature likely already produces adequate nitric oxide and you'll see minimal benefit. The practical guidance: 3,000 mg daily for postmenopausal women with high blood pressure, 6,000 mg split-dose for cold-sensitive individuals, and always choose pure L-citrulline over citrulline malate.
Read the full Aviado analysis →Research & Papers
Epigenetic Clocks Are Going Consumer — Here's What They Actually Tell You
A review in Biogerontology maps the evolution from Horvath's original methylation clock through GrimAge and DunedinPACE, noting that newer models predict disease risk and pace of aging more usefully than chronological age alone. Direct-to-consumer epigenetic testing is proliferating, but the authors flag a critical scalability barrier: most validated clocks rely on hundreds of CpG sites requiring expensive, high-throughput lab processing. A promising alternative — ELOVL2-based clocks — offers simpler, more affordable biological age assessment without sacrificing meaningful predictive accuracy, potentially democratizing access to one of longevity science's most powerful tools.
Read more →Metformin Use Linked to 55–67% Lower Risk of Blood Cancers in New Analysis
A study covered by CancerNetwork found that metformin users had dramatically lower odds of being diagnosed with myeloproliferative neoplasms — clonal blood cancers that rise sharply with age — with a 67% reduced risk for essential thrombocythemia (aOR 0.33) and a 55% lower risk for polycythemia vera (aOR 0.45). The protective effect was consistent across MPN subtypes, adding another data point to the growing case that metformin's benefits extend well beyond glycemic control. This is observational data and doesn't confirm causation, but it will be of direct interest to the longevity community already tracking metformin's multi-system effects.
Read more →Lifestyle & Nutrition
When You Eat May Matter As Much As What You Eat: TRE Timing Linked to Lower Biological Age Across Organs
A large cross-sectional analysis of 4,890 NHANES participants found that moderate eating frequencies and fasting durations were associated with lower biological age indices for the heart, kidney, and liver — while both excessively long and excessively short fasting windows correlated with worse liver metabolic health and cardiovascular risk markers. The Goldilocks message is clear: extreme fasting durations aren't the goal. Notably, eating breakfast on time was independently linked to better cardiovascular biological age, adding weight to the emerging science of earlier eating windows over prolonged overnight fasts.
Read more →How Elite Athletes Are Rewriting the Limits of Physical Performance After 50
A New York Times Magazine piece examines the growing cohort of athletes competing at elite levels well past conventional retirement age — and what longevity science and modern coaching now understand about making it possible. The reporting synthesizes cutting-edge recovery protocols, hormonal optimization, and training periodization that are migrating from professional sports into health-conscious consumer practice. The implicit message challenges the "inevitable decline" narrative: what once looked like aging may be, in large part, a product of under-recovery and outdated programming.
Read more →Industry & Policy
Alector Halts Phase 2 Alzheimer's Trial After Futility Readout
Alector has stopped its Phase 2 study of nivisnebart — a microglial-targeting antibody designed to slow Alzheimer's progression — after early data indicated the drug was unlikely to meet its endpoints. The halt is another setback in the long search for disease-modifying therapies, but the swift futility call also reflects a maturing trial infrastructure that can identify failing drugs earlier, sparing patients from prolonged exposure and conserving resources for more promising candidates. The Alzheimer's pipeline remains active, but this result reinforces that neuroinflammation targeting alone may not be sufficient.
Read more →